Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

3 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 14, 2004 INO P 1,544 $8.80 $13,587 1,544 Direct · Acquired -99.7% (price as of 2026-10-02)
Sept. 14, 2004 INO P 3 $17647.06 $52,941 3 Direct · Acquired -100.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 13, 2005 INO Inovio Biomedical Corporation Common Stock Inovio Biomedical Corporation Common Stock (10,000) $3.34 May 12, 2015 10,000 Acquired
Sept. 14, 2004 INO Genetronics Biomedical Corp Common Stock Warrants Genetronics Biomedical Corporation Common Stock $8.80 May 10, 2009 1,544 Acquired
Aug. 6, 2004 INO Common Stock Common Stock (20,000) $0.93 Aug. 5, 2014 20,000 Acquired
June 17, 2004 INO Common Stock Common Stock (35,000) $1.33 June 16, 2014 35,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 1 holding

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
Nov. 25, 2003 INO Common Stock→ Common Stock (50,000) 50,000 Direct